Correction: miR155, TREM2, INPP5D: Disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer's amyloidopathy.

Autor: Gandy S; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. samuel.gandy@mssm.edu.; Department of Psychiatry and Alzheimer's Disease Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. samuel.gandy@mssm.edu.; James J Peters VA Medical Center, Bronx, NY, 10468, USA. samuel.gandy@mssm.edu., Ehrlich ME; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. michelle.ehrlich@mssm.edu.; Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. michelle.ehrlich@mssm.edu.; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. michelle.ehrlich@mssm.edu.
Jazyk: angličtina
Zdroj: Journal of neuroinflammation [J Neuroinflammation] 2023 Nov 30; Vol. 20 (1), pp. 288. Date of Electronic Publication: 2023 Nov 30.
DOI: 10.1186/s12974-023-02954-z
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje